All blog posts
Total 6 results for
Showing 6 out of 6 results
06 12月 2023
Competition law and biosimilars: Time for a new approach or not yet?
23 11月 2023
CMA issues guidance permitting drugs companies to work together on Combination Therapies
31 10月 2023
Another chapter in the "pay for delay" saga: General Court rules on the Teva-Cephalon settlement agreement
15 8月 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
15 6月 2023
Overview of EU and South African regulatory and competition law in the Pharma sector
09 2月 2023
Competition law developments in the pharma sector – 2022 round-up and what to expect in 2023
Showing 6 out of 6 results
Key contacts
Kyriakos Fountoukakos
Managing Partner, Competition/Antitrust, Regulation and Trade, Brussels
Veronica Roberts
Partner, Head of Competition/Antitrust, Regulation and Trade, UK, London
Linda Evans
Partner, Head of Competition/Antitrust, Regulation and Trade, Australia, Sydney
Adelaide Luke
Partner, Head of Competition, Asia, Hong Kong
Jean Meijer
Managing Partner, Johannesburg Office, Johannesburg and Africa Group
Kristien Geeurickx
Knowledge Counsel, London